Medtronic (MDT): Vaughan David Investments LLC added to its stake +8,200 shares
Vaughan David Investments LLC added to its stake in Medtronic, per its Q1 2026 13F.
- 407K
- Shares reported · +8,200 vs prior quarter
- 0.75%
- Disclosed portfolio weight
- $35.3M
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 12, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- Mar 20, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
- Apr 28, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
What came next
- May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
- May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.”
- Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
- Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market
- Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
- Aug 12, 2026FDARecall: Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft…
- Aug 12, 2026FDARecall: Grafton" DBM and Grafton Plus" DBM contain demineralized human bone tissue combined with an inert additive to yield a demineralized bone matrix (DBM) allograft…
- Aug 13, 2026FDAFDA device clearance: BIS Advance pEEG Module
- Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
- Aug 20, 2026FDARecall: Brand Name: MiniMed Flex Product Name: MiniMed Flex Insulin Pump Model/Catalog Numbers: MMT-8062; MMT-8072 Product Description: The MiniMed Flex pump is an alt…
- Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
- Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
- Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
- Aug 31, 2026FDARecall: Medtronic Biopsy Needle Kit, REF: 9733068, Passive, Sterile EO, Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801075, Sterile EO, 5/Tray 12 Pk., Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801074, Sterile EO, 4/Tray 12 Pk., Rxonly
- Aug 31, 2026FDARecall: Medtronic NDI Passive Spheres REF: 8801071, Sterile EO, 1/Tray 12 pk., Rxonly
- Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
- Sep 2, 2026FDARecall: Generic Name: MiniMed Go App Generic Name: MiniMed Go App Model/Catalog Number: MMT-8600 (iOS), MMT-8601 (Android) Software Version: Software version 1.2.1 Pro…
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Medtronic
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.
How this filing works
Explore the data
Common questions
What does this filing report about Medtronic (MDT) stock?
Vaughan David Investments LLC added to its stake in Medtronic, per its Q1 2026 13F. Now 407K shares, $35.3M reported value, 0.75% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 12, 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Medtronic recently?
For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.
Does this mean MDT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Medtronic
- SEC Form 4Oct 16, 2026
- SEC Form 4Oct 16, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 144Oct 15, 2026
- SEC Form 4Sep 18, 2026
- SEC Form 144Sep 16, 2026
Everything OQRO holds on this company is on its MDT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
